Funding for this research was provided by:
Knut och Alice Wallenbergs Stiftelse
Familjen Erling-Perssons Stiftelse
Received: 28 March 2021
Accepted: 5 August 2021
First Online: 27 August 2021
: Lars Ny received a research grant from MSD and Syndax Pharmaceuticals to support some aspects of the PEMDAC study. Anders Ståhlberg is the coinventor of SiMSen-Seq (ctDNA measurement), is a board member of, and has stock ownership in SiMSen Diagnostics. The remaining authors declare no conflict of interest.